Thursday 7th October 2021The reality of ATMP delivery: pharmacy learning and future developmentsVIRTUAL EVENT : 10am-4pm (UK BST)
This is the second one day Pan UK Pharmacy Working Group for ATMPs / JPAG conference, this time to be held virtually. Advanced Therapy Medicinal Products (ATMPs) have revolutionised the treatment of some diseases, particularly those which were previously regarded as intractable to treatment and cure. ATMPs are biological medicines and can be defined by four main categories; in-vivo gene therapies, ex-vivo gene therapies, somatic cellular therapies and tissue engineered products.
As increasing numbers of ATMPs are now being seen through clinical trials and acquiring marketing authorisations. This joint JPAG and Pan UK Pharmacy Working Group for ATMPs symposium will inform and educate the audience about hot topics in the ATMP world.
Anne Black - NHS
Ben Doak - National Senior Programme of Care Manager, Innovative Treatments, NHSEI
Nia Evans - University Hospital of Wales
Imran Kausar - Novartis Gene Therapies
Prof Luigi Martini - Royal Pharmaceutical Society
Dr Cathy McKenzie - Kings College Hospital
Ian Rees - MHRA
Dr Ceri Roberts - NHSBT
Dr Justine Scanlan - Head of Specialist Pharmacy Service
Nisha Shaunak - Guys & St Thomas NHS Foundation Trust
John Spoors - Head of Commercial Medicines Policy Analysis, NHSEI
Prof Neil Watson - Newcastle Hospitals and Director of the Northern Alliance Advanced Therapies Treatment Centre (NA-ATDETAILS AND REGISTRATION